Clinical Trial Update: High Dose CHOP in Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating high-dose CHOP chemotherapy in patients with Non-Hodgkin's Lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Vincristine (vincristine)

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Non-Hodgkin's Lymphoma | Phase 2 | Status: COMPLETED